Journals / Cukurova Medical Journal / 2022 / Cilt: 47 - Sayı: 2

A comparative evaluation of the angiopoietin-like protein 8 (ANGPTL8) and alarin levels in patients with type 2 diabetes mellitus

Tip 2 diyabetli hastalarda angiopoietin benzeri protein 8 (ANGPTL8) ve Alarin düzeylerinin karşılaştırmalı bir değerlendirmesi

Pages
589–595
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If this mechanism is more clearly elucidated, there may be a significant improvement in diabetic treatment projection.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: Type 2 Diabetes Mellitus (T2DM) is one of the most serious public health problems that affect millions of people worldwide.
📊
Key Findings & Data:There are 537 million adults diagnosed with diabetes worldwide and approximately 90% of these adults have type 2 diabetes.
💡
Conclusion & Impact:If this mechanism is more clearly elucidated, there may be a significant improvement in diabetic treatment projection.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: Type 2 Diabetes Mellitus (T2DM) is one of the most serious public health problems that affect millions of people worldwide. There are 537 million adults diagnosed with diabetes worldwide and approximately 90% of these adults have type 2 diabetes. The study examined angiopoietin-like protein 8 (ANGPTL8) and Alarin levels of the patients diagnosed with T2DM in comparison with each other and with the healthy control group. Materials and Methods: The study was conducted with a diabetes group consisting of 67 patients who were newly diagnosed with T2DM and who did not use any medication, and the control group consisting of 55 healthy people. ANGPTL8 and Alarin levels were measured using the ELISA (enzyme-linked immunosorbent assay) method. Results: We found a significant increase in alarin and ANGPTL8 levels in the diabetic group compared to the control group. Furthermore, a positive correlation between Alarin levels and ANGPTL8, triglyceride, and insulin levels was found in the patient group. In addition, while both adipokines were higher in males in the patient group, both adipokines levels were lower in males than females in the control group, and there was a significant difference in ANGPTL8 levels. Conclusion: High levels of ANGPTL8 and Alarin may facilitate the development of diabetes through the insulin resistance pathway. If this mechanism is more clearly elucidated, there may be a significant improvement in diabetic treatment projection.

Özet

Amaç: Tip 2 Diabetes Mellitus (T2DM), dünya çapında milyonlarca insanı etkileyen en ciddi halk sağlığı sorunlarından biridir. Dünyada diyabet teşhisi konan 537 milyon yetişkin mevcuttur ve bu yetişkinlerin yaklaşık %90'ı tip 2 diyabet hastasıdır. Çalışmamızda T2DM tanısı alan hastaların angiopoietin benzeri protein 8 (ANGPTL8) ve alarin düzeylerini kendi aralarında ve sağlıklı kontrol grubu ile karşılaştırmalı olarak inceledik. Gereç ve Yöntem: Çalışmamız yeni T2DM tanısı almış ve herhangi bir ilaç kullanmayan 67 hastadan oluşan diyabet grubu ve 55 sağlıklı kişiden oluşan kontrol grubu ile yapıldı. ANGPTL8 ve Alarin seviyeleri ELISA (enzyme-linked immunosorbent assay) yöntemi kullanılarak ölçüldü. Bulgular: Kontrol grubuna kıyasla diyabetik grupta Alarin ve ANGPTL8 düzeylerinde anlamlı bir artış bulduk. Hasta grubunda alarin düzeyleri ile ANGPTL8, trigliserit ve insülin düzeyleri arasında pozitif bir ilişki bulunmuştur. Ayrıca hasta grubunda erkeklerde her iki adipokin düzeyi daha yüksek iken, kontrol grubunda erkeklerde her iki adipokin düzeyinin kadınlara göre daha düşük olduğu ve ANGPTL8 düzeylerinde anlamlı farklılık olduğu sonucuna vardık. Sonuç: Yüksek ANGPTL8 ve Alarin düzeylerinin insülin direnci yolu ile diyabet gelişimini kolaylaştırabileceğidüşünülmüştür. Bu mekanizma daha net bir şekilde aydınlatılırsa diyabetik tedavi projeksiyonunda önemli bir iyileşme olabilir.

🔖

Cite This Article

TİMURKAAN, M., AYYILDIZ, H. (2022). A comparative evaluation of the angiopoietin-like protein 8 (ANGPTL8) and alarin levels in patients with type 2 diabetes mellitus. Cukurova Medical Journal, Cilt: 47 - Sayı: 2, 589–595. https://ajindex.com/articles/476829

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Rosen ED, Kaestner KH, Natarajan R, Patti ME, Sallari R, Sander M et al. Epigenetics and epigenomics: Implications for diabetes and obesity. Diabetes. 2018;67:1923–31
  2. IDF Diabetes Atlas 2021. 10th Edition. https://www.idf.org/news/240:diabetes-nowaffects-one-in-10-adults-worldwide.html (accessed Feb 2022)
  3. Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005; 26:19-39
  4. Samuel VT, Shulman GI. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux. J Clin Invest. 2016;126:12-22
  5. Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab. 2012;303:334-51 6. Zhang R. Lipasin, a novel nutritionally-regulated liverenriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun. 2012;424:786-92
  6. Quagliarini F, Wang Y, Kozlitina J, Grishin NV, Hyde R, Boerwinkle E et al. Atypical angiopoietin-like protein that regulates ANGPTL3. Proc Natl Acad Sci U S A. 2012;109:19751-6
  7. Yi P, Park JS, Melton DA. Betatrophin: a hormone that controls pancreatic beta cell proliferation. Cell. 2013;153:747–58
  8. Santic R, Fenninger K, Graf K, Schneider R, Hauser KC, Schilling FH et al. Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene. J Mol Neurosci. 2006;29:145-52
  9. Santic R, Schmidhuber SM, Lang R, Rauch I, Voglas E, Eberhard N et al. Alarin is a vasoactive peptide. Proc Natl Acad Sci U S A. 2007;104,10217–22
  10. Guo L, Shi M, Zhang L, Shao H, Fang P, Ma Y et al. Galanin antagonist increases insulin resistance by reducing glucose transporter 4 effect in adipocytes of rats. Gen Comp Endocrinol. 2012;173:159–63
  11. Liang Y, Sheng S, Fang P, Ma Y, Li J, Shi Q et al. Exercise-induced galanin release facilitated GLUT4 translocation in adipocytes of type 2 diabetic rats. Pharmacol Biochem Behav. 2012;100:554–9
  12. Zhang Z, Sheng S, Guo L, Li G, Zhang L, Zhang L et al. Intracerebroventricular administration of galanin antagonist sustains insulin resistance in adipocytes of type 2 diabetic trained rats. Mol Cell Endocrinol. 2012;361:213–8
  13. DeFronzo RA. Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes. 2009;58:773–95
  14. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867
  15. MacDougald OA, Burant CF